arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2603.05532physics.chem-phcs.AI
收藏

人工智能在药物发现中的可靠性:对Boltz-2在结构和结合亲和力预测评估

On the Reliability of AI Methods in Drug Discovery: Evaluation of Boltz-2 for Structure and Binding Affinity Prediction

Shunzhou Wan, Xibei Zhang, Xiao Xue, Peter V. Coveney

AI总结:

本文评估了Boltz-2在药物发现中的可靠性,发现其在结构预测和结合亲和力预测中存在局限,需结合物理方法提高准确性。

摘要:

尽管关于人工智能在药物发现中作用的 hype 仍在持续,但迄今为止还没有“人工智能发现的药物”获得监管批准。在这里,我们评估了该领域中最新的人工智能工具之一。快速预测蛋白质-配体结构和结合亲和力的能力对于加速药物发现至关重要。Boltz-2 是一种 recently 开发的生物分子基础模型,旨在通过联合“共折叠”方法弥合人工智能效率与基于物理的精度之间的差距。在本研究中,我们使用两个大规模数据集对 Boltz-2 进行了广泛的评估:16,780 种化合物用于 3CLPro 和 21,702 种化合物用于 TNKS2。我们将 Boltz-2 预测的结构与传统的对接和结合亲和力与基于物理的 ESMACS 协议得出的结合自由能进行比较。结构分析显示了显著的全局 RMSD 变化,表明 Boltz-2 预测了多种蛋白质构象和配体结合位置,而不是单一收敛的构象。能量评估在全局数据集中显示出只有弱到中等的相关性。此外,对前 100 种化合物的聚焦分析显示,Boltz-2 预测与基于细粒度 ESMACS 得出的结合自由能之间没有显著相关性,同时观察到配体结构的饱和差异。我们的结果表明,尽管 Boltz-2 提供了初步筛选的大量速度,但它缺乏用于先导识别所需的能量分辨率。这些发现突显了在人工智能衍生模型的可靠性和细化中使用基于物理的方法的必要性。

英文摘要:

Despite continuing hype about the role of AI in drug discovery, no "AI-discovered drugs" have so far received regulatory approval. Here we assess one of the latest AI based tools in this domain. The ability to rapidly predict protein-ligand structures and binding affinities is pivotal for accelerating drug discovery. Boltz-2, a recently developed biomolecular foundation model, aims to bridge the gap between AI efficiency and physics-based precision through a joint "co-folding" approach. In this study, we provide an extensive evaluation of Boltz-2 using two large-scale datasets: 16,780 compounds for 3CLPro and 21,702 compounds for TNKS2. We compare Boltz-2 predicted structures with traditional docking and binding affinities with binding free energies derived from the physics-based ESMACS protocol. Structural analysis reveals significant global RMSD variations, indicating that Boltz-2 predicts multiple protein conformations and ligand binding positions rather than a single converged pose. Energetic evaluations exhibit only weak to moderate correlations across the global datasets. Furthermore, a focused analysis of the top 100 compounds yields no significant correlation between the Boltz-2 predictions and the binding free energies from fine-grained ESMACS, alongside observed saturation difference in ligand structures. Our results show that while Boltz-2 offers substantial speed for initial screening, it lacks the energetic resolution required for lead identification. These findings highlight the necessity of employing physics-based methods for the reliability and refinement of AI-derived models.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑